证券之星消息，截至2025年12月4日收盘，中红医疗(300981)报收于15.21元，上涨3.82%，换手率 4.84%，成交量19.02万手，成交额2.83亿元。 12月4日的资金流向数据方面，主力资金净流出1582.07万元，占总成交额5.59%，游资资金净流入 1205.2万元，占总成交额4.26%，散户资金净流入376.86万元，占总成交额1.33%。 近5日资金流向一览见下表： | 指标 | 中红医疗 | 医疗器械行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 65.23亿元 | 109.58亿元 | 54 124 | | 净资产 | 55.08亿元 | 38.93亿元 | 25 124 | | 净利润 | -721.02万元 | 2.12亿元 | 100 124 | | 市盈率(动) | -678.53 | 60.57 | - 124 | | 市净率 | 1.22 | 3.81 | 14 124 | | 毛利率 | 10.54% | 51.22% | 123 124 | | 净利率 | -0.51% | 9.57% | 98 124 | | ROE ...

Core Viewpoint - Zhonghong Medical (300981) experienced a decline in stock price, closing at 14.4 yuan on August 29, 2025, down 2.9% with a trading volume of 83,000 hands and a turnover of 120 million yuan [1][2]. Fund Flow Summary - On August 29, 2025, the net outflow of main funds was 17.4 million yuan, accounting for 14.44% of the total turnover, while retail investors saw a net inflow of 23.0 million yuan, representing 19.12% of the total turnover [1][2]. - Over the past five days, the stock has seen fluctuating fund flows, with significant net outflows from main and speculative funds on multiple days, particularly on August 28, where the main funds had a net outflow of 41.2 million yuan [2][3]. Financing and Securities Lending Data - As of August 29, 2025, the financing balance was 129 million yuan, with a net repayment of 4.43 million yuan. The securities lending showed no shares sold or repaid, with a remaining quantity of 4,820 shares and a balance of 69,400 yuan [3]. - The financing balance has decreased from 133 million yuan on August 28, 2025, indicating a trend of net repayments over the past few days [3]. Company Performance Metrics - Zhonghong Medical reported a total market value of 6.103 billion yuan, with a net asset value of 5.524 billion yuan and a net profit of 5.7429 million yuan, which is significantly lower than the industry average [5]. - The company’s main revenue for the first half of 2025 was 1.238 billion yuan, a year-on-year increase of 7.76%, but the net profit decreased by 82.35% to 5.7429 million yuan [5]. - The gross profit margin was reported at 11.36%, which is considerably lower than the industry average of 51.85%, indicating potential challenges in profitability [5].

Core Viewpoint - Zhonghong Medical (300981) experienced a decline in stock price, closing at 16.01 yuan on August 26, 2025, down 1.72% with a trading volume of 90,000 hands and a turnover of 144 million yuan [1] Group 1: Stock Performance and Trading Data - On August 26, 2025, the net outflow of main funds was 10.797 million yuan, accounting for 7.47% of the total turnover, while retail investors saw a net inflow of 12.0068 million yuan, representing 8.31% of the total turnover [1] - The stock's performance over the past five days shows fluctuations, with a peak closing price of 16.29 yuan on August 25, 2025, and a significant drop of 4.01% on August 20, 2025 [2] Group 2: Financial Metrics and Industry Comparison - Zhonghong Medical's total market value is 6.866 billion yuan, which is below the industry average of 12.328 billion yuan, ranking 53 out of 123 in the medical device industry [3] - The company reported a net profit of 18.9211 million yuan for Q1 2025, a significant increase of 1369.95% year-on-year, with a gross margin of 13.36%, which is considerably lower than the industry average of 51.29% [3] - The company's return on equity (ROE) stands at 0.35%, compared to the industry average of 1.83%, indicating a lower profitability relative to peers [3]

Core Viewpoint - Zhonghong Medical (300981) experienced a slight decline in stock price, closing at 15.95 yuan on August 22, 2025, with a trading volume of 9.89 million shares and a total transaction amount of 1.57 billion yuan [1] Group 1: Financial Performance - The company reported a main revenue of 629 million yuan for Q1 2025, representing a year-on-year increase of 15.45% [3] - The net profit attributable to shareholders was 18.92 million yuan, showing a significant year-on-year increase of 1369.95% [3] - The net profit after deducting non-recurring gains and losses was 11.37 million yuan, up 164.39% year-on-year [3] - The company's debt ratio stands at 24.09% [3] Group 2: Market Position and Ratios - Zhonghong Medical's total market value is 6.84 billion yuan, compared to the industry average of 12.243 billion yuan, ranking 53 out of 123 in the industry [3] - The company's net assets are 5.64 billion yuan, above the industry average of 3.893 billion yuan, ranking 23 out of 123 [3] - The price-to-earnings ratio (P/E) is 90.38, higher than the industry average of 77.99, ranking 73 out of 123 [3] - The price-to-book ratio (P/B) is 1.27, significantly lower than the industry average of 4.01, ranking 13 out of 123 [3] - The gross margin is 13.36%, while the industry average is 51.31%, ranking 121 out of 123 [3] - The net margin is 3.08%, compared to the industry average of 10.85%, ranking 94 out of 123 [3] - The return on equity (ROE) is 0.35%, lower than the industry average of 1.65%, ranking 94 out of 123 [3] Group 3: Capital Flow Analysis - On August 22, 2025, the main funds experienced a net outflow of 23.52 million yuan, accounting for 14.95% of the total transaction amount [1][2] - Retail investors saw a net inflow of 24.21 million yuan, representing 15.38% of the total transaction amount [1][2] - Over the past five days, the stock has seen fluctuating capital flows, with notable outflows from main and speculative funds on several days [2]

Core Viewpoint - Zhonghong Medical (300981) experienced a decline in stock price, closing at 16.28 yuan on August 20, 2025, down 4.01% with a trading volume of 179,500 shares and a turnover of 293 million yuan [1][2]. Fund Flow Summary - On August 20, 2025, the net outflow of main funds was 31.42 million yuan, accounting for 10.73% of the total turnover, while retail investors saw a net inflow of 34.66 million yuan, representing 11.84% of the total turnover [1][2]. - Over the past five days, the stock showed fluctuations in fund flows, with notable net inflows from retail investors on several days despite the overall decline in stock price [2]. Financing and Margin Trading Data - On August 20, 2025, the financing balance was 137 million yuan, with a net financing purchase of 4.425 million yuan. The stock had a margin balance of 137 million yuan [3]. - The stock's margin trading data indicates a stable borrowing situation, with no shares sold short on August 20, 2025 [3]. Company Performance Metrics - Zhonghong Medical's total market capitalization is 7.003 billion yuan, with a net asset value of 5.64 billion yuan and a net profit of 18.92 million yuan [5]. - The company's gross margin stands at 13.36%, significantly lower than the industry average of 51.29%, indicating potential challenges in profitability compared to peers [5]. - In the first quarter of 2025, the company reported a revenue of 629 million yuan, a year-on-year increase of 15.45%, and a net profit increase of 1369.95% [5].

Core Viewpoint - Zhonghong Medical (300981) has shown a stable stock price with a closing price of 16.24 yuan as of August 18, 2025, with no change in percentage [1] Group 1: Stock Performance and Fund Flow - The stock's trading volume on August 18 was 166,900 hands, with a total transaction amount of 272 million yuan [1] - The net outflow of main funds was 9.0382 million yuan, accounting for 3.33% of the total transaction amount, while retail investors saw a net inflow of 16.3396 million yuan, representing 6.01% of the total [1] - Over the past five days, the stock has experienced fluctuations in fund flow, with significant net outflows from main and speculative funds on several days [2] Group 2: Company Financials and Industry Comparison - Zhonghong Medical's total market value is 6.965 billion yuan, ranking 54th in the medical device industry [3] - The company reported a net profit of 18.9211 million yuan for Q1 2025, a year-on-year increase of 1369.95%, with a main business revenue of 629 million yuan, up 15.45% year-on-year [3] - The company's gross profit margin stands at 13.36%, significantly lower than the industry average of 51.35%, indicating potential challenges in profitability [3]

Core Insights - Zhonghong Medical (300981) experienced a significant decline in stock price, closing at 16.0 yuan on August 14, 2025, down 9.91% with a trading volume of 261,300 shares and a turnover of 431 million yuan [1][2] Financial Performance - The company reported a main revenue of 629 million yuan for Q1 2025, representing a year-on-year increase of 15.45% [4] - The net profit attributable to shareholders was 18.92 million yuan, up 1369.95% year-on-year, while the net profit excluding non-recurring items was 11.37 million yuan, increasing by 164.39% [4] - The company's debt ratio stands at 24.09%, with investment income of 963,200 yuan and financial expenses of -964,350 yuan [4] Market Position - Zhonghong Medical's total market capitalization is 7.076 billion yuan, which is below the industry average of 11.804 billion yuan, ranking 53 out of 123 in the medical device sector [4] - The company has a price-to-earnings (P/E) ratio of 93.5, significantly higher than the industry average of 66.07, ranking 77 out of 123 [4] - The gross margin is 13.36%, which is considerably lower than the industry average of 51.36%, ranking 121 out of 123 [4] Capital Flow - On August 14, 2025, the net outflow of main funds was 50.16 million yuan, accounting for 11.63% of the total turnover, while retail investors saw a net inflow of 47.92 million yuan, representing 11.11% of the total turnover [1][2] - The financing data indicates a net financing purchase of 10.84 million yuan on the same day, with a cumulative net purchase of 19.88 million yuan over the past three days [1][2]

Core Viewpoint - Zhonghong Medical (300981) has shown a slight increase in stock price, with a closing price of 17.76 yuan on August 13, 2025, reflecting a 1.66% rise, while the overall market sentiment indicates mixed capital flows [1][2]. Group 1: Stock Performance - As of August 13, 2025, Zhonghong Medical's stock price closed at 17.76 yuan, with a trading volume of 321,500 hands and a total transaction amount of 555 million yuan [1]. - The stock experienced a net outflow of 700.7 thousand yuan from main funds, accounting for 1.26% of the total transaction amount, while retail investors saw a net inflow of 693.8 thousand yuan, representing 1.25% of the total [1][2]. Group 2: Recent Capital Flows - Over the past five days, the stock has seen fluctuating capital flows, with notable net inflows and outflows from different investor categories [2]. - On August 12, 2025, the stock price was 17.47 yuan, with a significant increase of 4.74%, but main funds recorded a net outflow of 627.92 thousand yuan [2]. Group 3: Company Financials and Industry Comparison - Zhonghong Medical's total market capitalization is 7.617 billion yuan, with a net asset value of 5.64 billion yuan and a net profit of 18.92 million yuan [3]. - The company's gross margin stands at 13.36%, significantly lower than the industry average of 51.34%, indicating potential challenges in profitability compared to peers [3]. - The first quarter of 2025 reported a 15.45% year-on-year increase in main revenue, with a substantial rise in net profit by 1369.95% [3].

Group 1 - The stock of Zhonghong Medical (300981) closed at 13.87 yuan on August 5, 2025, down 2.53% with a turnover rate of 3.6% and a trading volume of 141,400 hands, resulting in a transaction amount of 198 million yuan [1] - On August 5, 2025, the net outflow of main funds was 14.26 million yuan, accounting for 7.21% of the total transaction amount, while retail investors had a net inflow of 13.95 million yuan, accounting for 7.06% [1] - The financing data on August 5 showed a financing buy of 19.83 million yuan and a financing repayment of 20.04 million yuan, resulting in a net repayment of 210,000 yuan [1][2] Group 2 - Zhonghong Medical's total market value is 5.948 billion yuan, with a net asset of 5.64 billion yuan and a net profit of 18.92 million yuan, ranking 58th, 24th, and 67th respectively in the medical device industry [4] - The company's gross profit margin is 13.36%, significantly lower than the industry average of 51.31%, ranking 121st in the industry [4] - In the first quarter of 2025, Zhonghong Medical reported a main revenue of 629 million yuan, a year-on-year increase of 15.45%, and a net profit attributable to shareholders of 18.92 million yuan, a year-on-year increase of 1369.95% [4]